Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 98 results
A clear vial of liquid on a lab bench with blurred lab equipment in the background.

Jul 6, 2026

Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies

Katalyze AI has secured $10.5 million in seed funding to enhance its agentic operating system tailored for pharmaceutical companies, aiming to streamline complex processes in drug development.This funding round, led by Bonfire Ventures with participation from several other investors, underscores the urgent need for innovation in the pharmaceutical sector, where challenges such as patent expirations and drug shortages are mounting. Katalyze AI's platform allows scientists and engineers to create
A minimalist illustration of a vaccine vial and a cell on a dark background.

Jun 29, 2026

China’s first AI-powered cancer vaccine production line set to launch in Beijing

China is launching its first production line for AI-assisted personalized cancer vaccines, a significant advancement in the fight against cancer, which is the second leading cause of death in the country.Beijing-based Likang Life Sciences is set to complete a new drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October. This facility, with an investment of approximately 110 million yuan (around US$16.1 million), will focus on developing cell th
A minimalist representation of a banknote symbolizing funding in biotechnology.

Jun 27, 2026

Immuneel Therapeutics Secures Over INR 100 Cr Series B Funding

Bengaluru-based Immuneel Therapeutics has successfully raised over INR 100 crore in its Series B funding round, with backing from both existing and new investors. This funding is set to enhance their manufacturing capabilities, advance their therapy pipeline, and facilitate entry into international markets.The funding round attracted notable participation from new investors, including Singularity AMC and Rainmatter by Zerodha, alongside continued support from existing investors like Kiran Mazumd
A minimalist representation of a drug compound in flat design.

Jun 26, 2026

AI in Biologics CDMO Workflows: A BIO Conversation with Lonza

At the 2026 BIO International Convention, Zara Asgharpour, Head of External Innovation Integrated Biologics at Lonza, highlighted the transformative potential of artificial intelligence (AI) in biologics workflows. Her insights emphasized the integration of AI across the entire biopharmaceutical value chain, from drug discovery to manufacturing and clinical trials.Asgharpour articulated that AI is set to revolutionize the operations of Contract Development and Manufacturing Organizations (CDMOs)
A minimalist representation of a pill and an API silhouette in a dark color scheme.

Jun 24, 2026

India needs quantum jump into manufacturing high-value pharma products: Economists

India's pharmaceutical sector is being urged to enhance its focus on high-value products, including Active Pharmaceutical Ingredients (APIs), according to economists who referenced a recent NITI Aayog report. The report highlights India's strengths in generic medicines and vaccines but calls for a strategic shift to boost exports of higher-value pharmaceuticals.Economist Ved Jain emphasized the need for substantial investment in research and innovation to develop basic drugs and manufacturing fa
A minimalist illustration of a syringe and vial in flat design.

Jun 23, 2026

Pharma MES 2026

The Pharma MES 2026 event is set to connect over 750 industry professionals, focusing on the evolving landscape of manufacturing in the life sciences sector.The life sciences industry faces mounting pressure to enhance product quality while reducing costs and improving operational efficiency. To meet these demands, organizations are increasingly adopting intelligent and sustainable manufacturing solutions that ensure compliance with current good manufacturing practices (cGMP) while facilitating
A minimalist illustration of a vaccine vial and production line in flat design.

Jun 23, 2026

AI in Pharma Manufacturing Market Size, Share | Growth [2034]

The global market for AI in pharmaceutical manufacturing is on a significant growth trajectory, with projections indicating an increase from USD 1.64 billion in 2026 to USD 12.90 billion by 2034, achieving a compound annual growth rate (CAGR) of 29.45%.This expansion is driven by the increasing complexity of drug production, particularly in biologics, vaccines, and advanced therapies, which necessitate faster production cycles and enhanced quality control. AI technologies are being integrated in
Fermentation tank in a biomanufacturing facility

Jun 22, 2026

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

ChemT Biotechnology has successfully raised $5 million in funding to enhance its AI-driven biomanufacturing platform, with the seed round led by Wavemaker Ventures and participation from various notable investors.The funding consists of $1 million from angel investors and $4 million from a seed round aimed at expanding ChemT's AI capabilities and experimental infrastructure. The company's innovative approach seeks to streamline the manufacturing of biologics, which often face challenges such as
Minimalist illustration of a lab flask and Copenhagen skyline in dark colors with lime accents.

Jun 19, 2026

US biotech Anthology Biotechnologies establishes European headquarters in Copenhagen

Anthology Biotechnologies, a US-based biotech firm, has officially launched its European subsidiary in Copenhagen, marking a significant expansion into the European market.The company, founded in 2023 with ties to prestigious institutions like MIT, Boston University, and Harvard, aims to innovate biomanufacturing through the integration of genome engineering, hardware engineering, and artificial intelligence. The choice of Copenhagen as its European headquarters is strategic, given the region's
Flat illustration of a PCR test kit

Jun 18, 2026

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

Co-Diagnostics is advancing its collaboration with CoMira Diagnostics, a joint venture in Saudi Arabia, by showcasing its automated manufacturing capabilities aimed at enhancing local diagnostic production.The recent visit by a CoMira delegation to Co-Diagnostics’ headquarters in Salt Lake City marks a significant step in the partnership, which focuses on transferring technology to improve healthcare diagnostics in Saudi Arabia and surrounding regions. The event featured a tour of the company's
A minimalist illustration of a pill and a broken pill on a solid background.

Jun 6, 2026

When validated systems lose trust: why cyber risk is a Pharma 5.0 safety issue

The evolution of pharmaceutical manufacturing under Pharma 5.0 raises critical concerns regarding trust in validated systems, especially in the context of cyber risks.Pharmaceutical manufacturing is heavily reliant on controlled environments, validated processes, and stringent regulatory oversight to ensure product quality and patient safety. However, as the industry transitions to Pharma 5.0, which integrates automation, AI, and advanced analytics, the foundation of this trust is being challeng
A flat illustration of a protein structure in a minimalist style.

Jun 5, 2026

India’s biofoundry bet: Can the country leap into the AI–biotech race?

India is positioning itself in the competitive landscape of AI-driven biotechnology, aiming to establish robust biofoundries and biomanufacturing capabilities.A global shift is occurring as countries race to harness the potential of artificial intelligence in biological research. AI's ability to design proteins and biological systems at unprecedented speeds has highlighted a critical need for automated experimental platforms that can translate these designs into tangible products. India is respo